Pembrolizumab in Refractory Advanced Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Improving Communication Between Cancer Patients & Oncologists
- Status
- COMPLETED
- Phase
- NA
Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy
- Status
- COMPLETED
- Phase
- NA
Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides
- Status
- WITHDRAWN
- Phase
- PHASE2
STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
- Status
- COMPLETED
- Phase
- PHASE2
Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- Status
- RECRUITING
- Phase
- NA
Merestinib In Non-Small Cell Lung Cancer And Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Pembrolizumab in Metastatic Anal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- NA
Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency
- Status
- COMPLETED
- Phase
- PHASE2